Colocalization of Transactivation-Responsive DNA-Binding Protein 43 and Huntingtin in Inclusions of Huntington Disease
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Transactivation-responsive DNA-binding protein 43 (TDP-43) is a component of pathological inclusions in amyotrophic lateral sclerosis and several forms of sporadic and familial frontotemporal lobar degeneration. Transactivation-responsive DNA-binding protein 43-immunostained inclusions have also been found in other neurodegenerative disorders including Alzheimer disease, dementia with Lewy bodies, and parkinsonism dementia complex of Guam. Here, we analyzed the occurrence of TDP-43 immunostaining in Huntington disease, which is characterized by inclusions containing mutated huntingtin. In all Huntington disease cases studied, TDP-43 was frequently colocalized with huntingtin in dystrophic neurites and various intracellular inclusions, but not in intranuclear inclusions; the latter were only stained with huntingtin and anti-ubiquitin antibodies. Two phosphorylation-dependent TDP-43 antibodies proved to be superior for detecting pathological inclusions because they did not stain nonphosphorylated TDP-43 in normal nuclei; staining of normal nuclei with phosphorylation-independent antibodies obscured the inclusions. Our results further add to the hypothesis that TDP-43 may be involved in the pathology of a variety of neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 11×
“Transactivation-responsive DNA-binding protein 43 (TDP-43) has recently been identified as a component of ubiquitin-positive inclusions in several forms of sporadic and familial frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) (1, 2).”
BackgroundInfluentialArai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
Self-citationAggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Cairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110 · cited 1×
“subtype 4 [6, 7] or subtype 1 [5]), were not found in the HD cases.”
BackgroundMackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992 · cited 1×
“[ Transactivationresponsive DNA-binding protein 43 antibodies label inclusions in FTLD patients who carry mutations in the progranulin and valosin-containing protein genes and in chromosome 9Ylinked familial forms, but they do not label structures in patients with superoxide dismutase 1 mutations (6, 26, 27).”
BackgroundTDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916 · cited 1×
“Several reports described TDP-43Yimmunopositive inclusions in various proportions of cases with Alzheimer disease (20%Y33%) (10, 11), hippocampal sclerosis (70%) (10), parkinsonism dementia complex of Guam (12, 13), diffuse Lewy body disease, Parkinson disease (11, 14), and corticobasal degeneration (15); in some repo…”
BackgroundPhosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Hasegawa, M., Arai, T., Nonaka, T., Kametani, F., Yoshida, M., Hashizume, Y., Beach, T. G., Buratti, E., Baralle, F., Morita, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21425 · Cited by 777 · cited 3×
“In the ALS case, the pTDP-43(pS403/404) and pTDP43(pS409/410) antibodies stained skeinlike and spherical inclusions in anterior horn neurons of the spinal cord as reported by Hasegawa and colleagues (23) (Fig.”
BackgroundSelf-citationOu, S. H., Wu, F., Harrich, D., García-Martínez, L. F., & Gaynor, R. B. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3584-3596.1995 · Cited by 758
Reduction of Lipofuscin-like Autofluorescence in Fluorescently Labeled Tissue
Schnell, S. A., Staines, W. A., & Wessendorf, M. W. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700601 · Cited by 688
Graham, R. K., Deng, Y., Slow, E. J., Haigh, B., Bissada, N., Lu, G., Pearson, J., Shehadeh, J., Bertram, L., Murphy, Z., et al. (2006) · Cell · doi:10.1016/j.cell.2006.04.026 · Cited by 651
Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping
Buratti, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1774 · Cited by 631
TDP-43 in Familial and Sporadic Frontotemporal Lobar Degeneration with Ubiquitin Inclusions
Cairns, N. J., Neumann, M., Bigio, E. H., Holm, I. E., Troost, D., Hatanpaa, K. J., Foong, C., White, C. L., Schneider, J. A., Kretzschmar, H. A., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070182 · Cited by 544
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases
Nakashima-Yasuda, H., Uryu, K., Robinson, J., Xie, S. X., Hurtig, H., Duda, J. E., Arnold, S. E., Siderowf, A., Grossman, M., Leverenz, J. B., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0261-2 · Cited by 468 · cited 3×
“Although in Lewy body disease TDP-43 inclusions were described more frequently in the superficial cortical layers (14), and Lewy bodies occur throughout the cortex in advanced Lewy body disease (28), we found that the TDP-43 inclusions were more numerous in the lower layers of the HD cortex, where htt inclusions predo…”
BackgroundResultHigashi, S., Iseki, E., Yamamoto, R., Minegishi, M., Hino, H., Fujisawa, K., Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.048 · Cited by 419
Huntington's disease: from pathology and genetics to potential therapies
Imarisio, S., Carmichael, J., Korolchuk, V., Chen, C.-W., Saiki, S., Rose, C., Krishna, G., Davies, J. E., Ttofi, E., Underwood, B. R., et al. (2008) · Biochemical Journal · doi:10.1042/bj20071619 · Cited by 409
Caspase Cleavage of Mutant Huntingtin Precedes Neurodegeneration in Huntington's Disease
Wellington, C. L., Ellerby, L. M., Gutekunst, C.-A., Rogers, D., Warby, S., Graham, R. K., Loubser, O., van Raamsdonk, J., Singaraja, R., Yang, Y.-Z., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07862.2002 · Cited by 399
Uryu, K., Nakashima-Yasuda, H., Forman, M. S., Kwong, L. K., Clark, C. M., Grossman, M., Miller, B. L., Kretzschmar, H. A., Lee, V. M.-Y., Trojanowski, J. Q., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31817713b5 · Cited by 382 · cited 1×
“Several reports described TDP-43Yimmunopositive inclusions in various proportions of cases with Alzheimer disease (20%Y33%) (10, 11), hippocampal sclerosis (70%) (10), parkinsonism dementia complex of Guam (12, 13), diffuse Lewy body disease, Parkinson disease (11, 14), and corticobasal degeneration (15); in some repo…”
BackgroundTDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein
Strong, M. J., Volkening, K., Hammond, R., Yang, W., Strong, W., Leystra-Lantz, C., & Shoesmith, C. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.03.007 · Cited by 349
Huntingtin localization in brains of normal and Huntington's disease patients
Sapp, E., Schwarz, C., Chase, K., Bhide, P. G., Young, A. B., Penney, J., Vonsattel, J. P., Aronin, N., & DiFiglia, M. (1997) · Annals of Neurology · doi:10.1002/ana.410420411 · Cited by 349
Igaz, L. M., Kwong, L. K., Xu, Y., Truax, A. C., Uryu, K., Neumann, M., Clark, C. M., Elman, L. B., Miller, B. L., Grossman, M., et al. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080003 · Cited by 327
Mackenzie, I. R. A., Baborie, A., Pickering-Brown, S., Plessis, D. D., Jaros, E., Perry, R. H., Neary, D., Snowden, J. S., & Mann, D. M. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0138-9 · Cited by 323
Ferrer, I., Gomez-Isla, T., Puig, B., Freixes, M., Ribe, E., Dalfo, E., & Avila, J. (2005) · Current Alzheimer Research · doi:10.2174/1567205052772713 · Cited by 304
Davidson, Y., Kelley, T., Mackenzie, I. R. A., Pickering-Brown, S., Du Plessis, D., Neary, D., Snowden, J. S., & Mann, D. M. A. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0189-y · Cited by 299
Tan, C.-F., Eguchi, H., Tagawa, A., Onodera, O., Iwasaki, T., Tsujino, A., Nishizawa, M., Kakita, A., & Takahashi, H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0206-9 · Cited by 298
TDP-43 is deposited in the Guam parkinsonism-dementia complex brains
Hasegawa, M., Arai, T., Akiyama, H., Nonaka, T., Mori, H., Hashimoto, T., Yamazaki, M., & Oyanagi, K. (2007) · Brain · doi:10.1093/brain/awm065 · Cited by 242
Self-citationLuna-Muñoz, J., Chávez-Macías, L., García-Sierra, F., & Mena, R. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-12410 · Cited by 233
Huntington's Disease Intranuclear Inclusions Contain Truncated, Ubiquitinated Huntingtin Protein
Sieradzan, K. A., Mechan, A. O., Jones, L., Wanker, E. E., Nukina, N., & Mann, D. M. A. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.7005 · Cited by 207
Pathological TDP-43 in parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam
Geser, F., Winton, M. J., Kwong, L. K., Xu, Y., Xie, S. X., Igaz, L. M., Garruto, R. M., Perl, D. P., Galasko, D., Lee, V. M.-Y., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0257-y · Cited by 188
Sapp, E., Penney, J., Young, A., Aronin, N., Vonsattel, J.-P., & DiFiglia, M. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199902000-00006 · Cited by 171
Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies
Marui, W., Iseki, E., Nakai, T., Miura, S., Kato, M., Uéda, K., & Kosaka, K. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00006-0 · Cited by 160
Warby, S. C., Doty, C. N., Graham, R. K., Carroll, J. B., Yang, Y., Singaraja, R. R., Overall, C. M., & Hayden, M. R. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn139 · Cited by 158
TDP-43 in differential diagnosis of motor neuron disorders
Dickson, D. W., Josephs, K. A., & Amador, C. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0234-5 · Cited by 157
Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer’s disease
Mondragón‐Rodríguez, S., Basurto‐Islas, G., Santa‐Maria, I., Mena, R., Binder, L. I., Avila, J., Smith, M. A., Perry, G., & García‐Sierra, F. (2008) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2007.00568.x · Cited by 146
Distribution of Inclusions in Neuronal Nuclei and Dystrophic Neurites in Huntington Disease Brain
Maat-Schieman, M. L. C., Dorsman, J. C., Smoor, M. A., Siesling, S., Van Duinen, S. G., Verschuuren, J. J. G. M., Den Dunnen, J. T., Van Ommen, G.-J. B., & Roos, R. A. C. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199902000-00003 · Cited by 99
Obi, K., Akiyama, H., Kondo, H., Shimomura, Y., Hasegawa, M., Iwatsubo, T., Mizuno, Y., & Mochizuki, H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.019 · Cited by 95
Self-citationCaspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease
Rohn, T. T. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.094 · Cited by 78
TDP-43 in neurodegenerative disorders
Cook, C., Zhang, Y.-J., Xu, Y.-F., Dickson, D. W., & Petrucelli, L. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.7.969 · Cited by 48
Neuronal Intranuclear and Neuropil Inclusions for Pathological Assessment of Huntington’s Disease
Maat–Schieman, M. L. C., Roos, R. A. C., Losekoot, M., Dorsman, J. C., Welling‐Graafland, C., Hegeman-Kleinn, I. M., Broeyer, F. J. F., Breuning, M. H., & van Duinen, S. G. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2006.00040.x · Cited by 30
Cited by
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Huelga, S. C., Moran, J., Liang, T. Y., Ling, S.-C., Sun, E., Wancewicz, E., Mazur, C., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2779 · Cited by 1,335
TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration
Lagier-Tourenne, C., Polymenidou, M., & Cleveland, D. W. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq137 · Cited by 1,021
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A., & Patel, B. K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00025 · Cited by 774
TDP‐43 is recruited to stress granules in conditions of oxidative insult
Colombrita, C., Zennaro, E., Fallini, C., Weber, M., Sommacal, A., Buratti, E., Silani, V., & Ratti, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06383.x · Cited by 539
TAR DNA-binding protein 43 in neurodegenerative disease
Chen-Plotkin, A. S., Lee, V. M.-Y., & Trojanowski, J. Q. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.18 · Cited by 468
Metadata
- Authors
- Schwab, C., Arai, T., Hasegawa, M., Yu, S., & McGeer, P. L.
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-12
- Volume
- 67
- Issue
- 12
- Pages
- 1159-1165
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W1990145006
- Cited by
- 271
- References
- 38
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.